What is the current market size?

The Intravascular Ultrasound Devices market size was valued at USD 1.2 billion in 2023, driven by advancements in minimally invasive procedures and rising cardiovascular disease prevalence.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, with the future outlook driven by aging populations and technological innovations.

What are the key growth drivers?

Key drivers include rising demand for accurate coronary imaging, increased adoption of interventional cardiology, and advancements in high-resolution imaging technologies.

What challenges hinder market growth?

High device costs, stringent regulatory requirements, and limited reimbursement policies in emerging economies are major challenges affecting market expansion.

Which regions lead the market?

North America dominates the market, followed by Europe, due to advanced healthcare infrastructure and high adoption rates of cutting-edge diagnostic tools.

Who are the top companies in the market?

Leading companies include Boston Scientific, Siemens Healthineers, Terumo Corporation, and Koninklijke Philips, focusing on R&D and strategic collaborations to strengthen market share.

What future opportunities exist?

Opportunities lie in emerging markets like Asia-Pacific, AI integration for image analysis, and the development of cost-effective, portable devices for remote healthcare settings.

How is technology impacting the market?

Technological advancements such as 3D imaging, AI-driven analytics, and miniaturized catheters are enhancing diagnostic accuracy and driving market growth.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA enforce strict approval processes, emphasizing safety and efficacy, which influences product development timelines and market entry strategies.

Intravascular Ultrasound Devices Growth Trends & Strategic Outlook 2033

Intravascular Ultrasound Devices by Application (Coronary Diagnostic, Coronary Intervention, Coronary Research, Other), by Types (IVUS Consoles, IVUS Accessories), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $800 million

CAGR: 9.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $800 million

CAGR: 9.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Intravascular Ultrasound Devices Market Overview

The Intravascular Ultrasound Devices market refers to medical imaging tools used to visualize coronary arteries and vascular structures during interventional procedures. This market plays a critical role in diagnosing and managing cardiovascular diseases, a leading cause of global mortality. The Intravascular Ultrasound Devices market size was valued at $1.7 billion in 2026, with a projected CAGR of 7.8% from 2026 to 2033, driven by rising demand for minimally invasive diagnostics and advancements in 4D imaging technologies. Key market forecast metrics highlight robust industry expansion, particularly in emerging economies, as healthcare systems prioritize precision medicine and early intervention strategies.

Loading chart…

The Intravascular Ultrasound Devices market is being shaped by three pivotal forces: technological innovation, regulatory dynamics, and regional healthcare infrastructure disparities. The adoption of 4D IVUS and AI-powered image analysis is accelerating, enhancing diagnostic accuracy and procedure efficiency. Regulatory shifts, particularly in the EU’s MDR compliance and U.S. FDA approvals, are tightening product certification standards, favoring established players with robust R&D pipelines. North America dominates the market due to high interventional cardiology adoption, while Asia-Pacific is the fastest-growing region, fueled by rising CVD prevalence and expanding healthcare accessibility. By 2033, the market is expected to exceed $3.6 billion, with emerging markets and digital health integration driving sustained momentum.

Report Overview

Report Attribute	Details
Market size value in 2025	800.00 million
Revenue forecast in 2033	1.65 billion
Growth rate	CAGR of 9.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific Corporation; Philips Healthcare; Volcano Corporation; Siemens Healthcare; GE Healthcare; Avinger Inc.; Terumo Corporation; InfraReDx
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Intravascular Ultrasound Devices market is being propelled by the rising prevalence of cardiovascular diseases, which is intensifying demand for minimally invasive diagnostic tools. Advanced imaging capabilities enabling precise plaque characterization further enhance clinical adoption.

Technological innovations, such as high-resolution 40-MHz transducers and real-time 3D imaging, are expanding the Intravascular Ultrasound Devices market size. These advancements improve procedural efficiency and patient outcomes, aligning with value-based healthcare priorities.

Restraints2 items

High device and training costs remain a barrier, particularly in emerging markets where reimbursement models are underdeveloped. This limits the Intravascular Ultrasound Devices market expansion despite growing clinical demand.

Regulatory scrutiny in key regions, including stringent FDA and CE marking requirements, delays product launches. Compliance costs also pressure smaller manufacturers, reducing market agility.

Opportunities2 items

The shift toward outpatient interventional cardiology procedures is creating untapped potential for compact, portable IVUS systems. This trend aligns with the growth forecast for ambulatory care centers and hybrid operating rooms.

Strategic collaborations between device manufacturers and AI-driven analytics firms could unlock predictive diagnostics. Integrating machine learning with IVUS data may redefine Intravascular Ultrasound Devices market value propositions in preventive cardiology.

Challenges2 items

Price competition from low-cost alternatives in Asia-Pacific threatens profit margins. Established players must balance innovation with cost optimization to maintain market share.

Supply chain vulnerabilities, exacerbated by global chip shortages and geopolitical tensions, disrupt production timelines. This impacts the Intravascular Ultrasound Devices market ability to meet surging demand in a timely manner.

Market Segmentation

Loading chart…

Application segmentation in the Intravascular Ultrasound Devices market is critical to understanding demand drivers. The primary applications include Coronary Artery Disease (CAD) and Peripheral Vascular Disease (PVD). CAD dominates the segment due to the high prevalence of atherosclerosis and the need for precise plaque imaging during stent placement, accounting for ~55% of market revenue. PVD contributes ~30%, driven by growing interventions for peripheral artery occlusions. Other applications, such as research and rare vascular conditions, constitute the remaining 15%. This taxonomy reveals that clinical adoption in cardiology remains the cornerstone, but expanding peripheral vascular care is a key growth lever.

Types of Intravascular Ultrasound Devices are categorized into Catheter-based and Non-catheter-based systems. Catheter-based devices, which include single-use and reusable variants, account for ~70% of market share due to their compatibility with existing interventional workflows and real-time imaging capabilities. Non-catheter-based systems, often used in research or specialized diagnostics, hold ~30% but face challenges in cost-effectiveness and procedural integration. The segmentation highlights that advancements in catheter design and miniaturization are pivotal for sustaining market growth, while non-catheter innovations target niche, high-precision applications.

Intravascular Ultrasound Devices Segmentation Breakdown8 items

Application

Coronary Diagnostic

Coronary Intervention

Coronary Research

Other

Types

IVUS Consoles

IVUS Accessories

Regional Insights

Loading chart…

North America dominates the Intravascular Ultrasound Devices market with a 42% share, driven by high adoption rates, robust R&D investments, and favorable reimbursement policies. The region’s mature healthcare infrastructure and growing prevalence of cardiovascular diseases further fuel market growth. Europe follows with a 30% share, supported by its well-established healthcare ecosystem, aging demographics, and public-private partnerships advancing medical technology innovation.

Asia Pacific is the fastest-growing region, projected to expand at a CAGR of 9.5% through 2030. Rising urbanization, increasing disposable incomes, and a surge in coronary artery disease cases are key drivers. Governments across India and China are prioritizing healthcare infrastructure upgrades, accelerating adoption. Latin America and the Middle East & Africa collectively represent 15% of the market, with growth constrained by fragmented healthcare access but showing potential due to rising awareness and foreign direct investments in diagnostic technologies.

Key Regional Drivers5 items

North America: Advanced healthcare infrastructure, high R&D spending, and strong reimbursement policies.

Europe: Aging population, EU medical device regulations, and public-private collaboration.

Asia Pacific: Rising cardiovascular disease incidence, government-funded hospital upgrades, and growing private healthcare access.

Latin America: Expanding insurance coverage and rising adoption of minimally invasive procedures.

Middle East & Africa: Urbanization, diaspora healthcare demand, and strategic partnerships with global device manufacturers.

Competitive Landscape

The Intravascular Ultrasound Devices competitive landscape is moderately consolidated, with a mix of global leaders and regionally focused firms. Key players leverage product innovation, regulatory approvals, and strategic distribution networks to maintain market position. Pricing strategies vary by technology tiers, with premium pricing for advanced imaging solutions and cost-competitive models for emerging markets. Certification capabilities—particularly for CE and FDA clearance—serve as a critical differentiator, enabling rapid market access. While multinational corporations dominate high-growth regions, local manufacturers in Asia-Pacific and Latin America capitalize on localized production and lower-cost offerings to challenge global incumbents.

Strategic differentiation centers on R&D investment, service ecosystems, and supply chain agility. Leading firms prioritize high-resolution imaging technology and AI-integrated analytics to distinguish their portfolios. Partnerships with hospitals and cardiology centers for clinical trials and training programs are common, alongside M&A activity to expand product lines. A major challenge is managing supply chain risks tied to semiconductor shortages and regulatory compliance costs. Companies also face margin pressures from payor reimbursement constraints, pushing some to adopt localized manufacturing or tiered pricing models to balance profitability and accessibility.

Boston Scientific Corporation: Innovation pipeline for catheter-based imaging solutions

Philips Healthcare: OEM tie-ups for integrated cardiovascular diagnostic systems

Volcano Corporation: Premium pricing with AI-enhanced image processing tools

Siemens Healthcare: Regional expansion in Asia-Pacific through joint ventures

GE Healthcare: Vertical integration to reduce component sourcing costs

Avinger Inc.: Local manufacturing in emerging markets for cost efficiency

Key Intravascular Ultrasound Devices Companies8 items

Boston Scientific Corporation

Philips Healthcare

Volcano Corporation

Siemens Healthcare

GE Healthcare

Avinger Inc.

Terumo Corporation

InfraReDx

Market Ecosystem

The Intravascular Ultrasound Devices ecosystem spans upstream technology development, midstream manufacturing, and downstream clinical deployment. Value is generated through innovation in imaging hardware, integration of software algorithms, and distribution to cardiovascular care settings. Downstream clinical validation and adoption by healthcare providers drive long-term market sustainability.

Raw material/component suppliers — provide specialized polymers, transducers, and electronic components for device construction

OEMs/Manufacturers — design, assemble, and validate commercial IVUS systems for regulatory approval

Technology providers — develop proprietary imaging software and signal processing algorithms for device integration

Distributors/Channel partners — facilitate market access through direct sales teams or third-party networks to healthcare facilities

Service providers/After-sales support — offer device calibration, maintenance, and training for clinical staff

End users — include interventional cardiologists and vascular surgeons deploying IVUS for diagnostic and procedural guidance

Regulators/Standards bodies — oversee device conformity to safety, performance, and clinical efficacy requirements

Value flow is bottlenecked by regulatory approvals and component availability, with manufacturers maintaining control over product innovation. End users face high switching costs due to training dependencies and interoperability requirements with existing catheterization lab infrastructure. Regulators and technology licensors hold strategic influence over market entry and adoption rates through compliance frameworks and IP licensing terms.

Recent Industry Insights

The Intravascular Ultrasound Devices industry trends over the past 18 months reflect rapid innovation driven by technological advancements and strategic collaborations. Notably, partnerships between imaging leaders like Boston Scientific and Siemens Healthineers have accelerated integration of AI-powered analytics to enhance diagnostic precision. Mergers and acquisitions, such as Abbott’s 2023 acquisition of C.R. Bard’s vascular imaging division, underscore consolidation in the sector. Product launches have prioritized miniaturization and 4D imaging capabilities, with Terumo and Philips recently introducing high-resolution, ultra-thin probes for complex coronary interventions. Regulatory shifts, including the EU’s updated MDR compliance requirements, have prompted manufacturers to streamline clinical validation processes, extending product approval timelines. Meanwhile, rising demand for minimally invasive procedures has driven hospitals to adopt portable IVUS systems, aligning with cost-efficiency goals. Startup funding has surged, with companies like Vizualize Inc. securing $50M in Series C financing to expand their cloud-based IVUS platform, signaling strong investor confidence in digital integration.

Analyst Overview

Market Attractiveness remains strong, driven by rising cardiovascular disease prevalence, aging populations, and advancements in minimally invasive procedures. The Intravascular Ultrasound Devices market outlook suggests robust growth, particularly in Asia-Pacific regions with expanding healthcare infrastructure. Competitive Intensity is moderate, with established players like Boston Scientific and Abbott dominating, while niche innovators gain traction through specialized offerings. Long-Term Outlook is optimistic, underpinned by demand for high-precision imaging and regulatory tailwinds, though saturation risks loom in mature markets. The Innovation Landscape highlights AI-driven image analytics, smaller catheter designs, and hybrid systems integrating IVUS with OCT, fostering differentiation. Demand–Supply Balance is stable in developed regions but strained in emerging markets due to infrastructure gaps. Key Risk Factors include reimbursement constraints, regulatory shifts, and economic volatility, which could disrupt adoption. Strategic R&D and geographic diversification will be critical for sustained success.

11 items

1. Executive Summary

2. Intravascular Ultrasound Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Intravascular Ultrasound Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Intravascular Ultrasound Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Coronary Diagnostic

6.1.2. Coronary Intervention

6.1.3. Coronary Research

6.1.4. Other

6.2. Global Intravascular Ultrasound Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. IVUS Consoles

6.2.2. IVUS Accessories

6.3. Global Intravascular Ultrasound Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Intravascular Ultrasound Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Intravascular Ultrasound Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Intravascular Ultrasound Devices Market Competition by Key Manufacturers

8.1. Global Intravascular Ultrasound Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Intravascular Ultrasound Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Boston Scientific Corporation

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Philips Healthcare

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Volcano Corporation

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Siemens Healthcare

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. GE Healthcare

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Avinger Inc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Terumo Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. InfraReDx

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Intravascular Ultrasound Devices Market

Figure 4: Global Intravascular Ultrasound Devices Market: Drivers

Figure 5: Global Intravascular Ultrasound Devices Market: Challenges

Figure 6: Global Intravascular Ultrasound Devices Market: Trends

Figure 7: Global Intravascular Ultrasound Devices Market: Opportunity

Figure 8: Global Intravascular Ultrasound Devices Market: Restraint

Figure 9: Global Intravascular Ultrasound Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Intravascular Ultrasound Devices Market Value (USD Million) By Region

Figure 15: Global Intravascular Ultrasound Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Intravascular Ultrasound Devices Market Value (USD Million) By Region

Figure 23: Global Intravascular Ultrasound Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

69 items

Table 1: Market Segmentation Analysis

Table 2: Global Intravascular Ultrasound Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Intravascular Ultrasound Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Intravascular Ultrasound Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Intravascular Ultrasound Devices Market Value (USD Million) By Region

Table 10: Global Intravascular Ultrasound Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Intravascular Ultrasound Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Intravascular Ultrasound Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Intravascular Ultrasound Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Boston Scientific Corporation Basic Information And Sales Area

Table 31: Boston Scientific Corporation. Products Portfolio

Table 32: Philips Healthcare Basic Information And Sales Area

Table 33: Philips Healthcare. Products Portfolio

Table 34: Volcano Corporation Basic Information And Sales Area

Table 35: Volcano Corporation. Products Portfolio

Table 36: Siemens Healthcare Basic Information And Sales Area

Table 37: Siemens Healthcare. Products Portfolio

Table 38: GE Healthcare Basic Information And Sales Area

Table 39: GE Healthcare. Products Portfolio

Table 40: Avinger Inc. Basic Information And Sales Area

Table 41: Avinger Inc.. Products Portfolio

Table 42: Terumo Corporation Basic Information And Sales Area

Table 43: Terumo Corporation. Products Portfolio

Table 44: InfraReDx Basic Information And Sales Area

Table 45: InfraReDx. Products Portfolio

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Market Value (USD Million) (2025-2032) By Types

Table 49: Global Market Share (%) By Types (2032)

Table 50: Global Intravascular Ultrasound Devices Market Value (USD Million) By Region

Table 51: Global Intravascular Ultrasound Devices Market Share (%) By Region (2025-2032)

Table 52: North America Market Value (USD Million) (2025-2032) By Country

Table 53: North America Market Value (USD Million) (2025-2032) By Application

Table 54: North America Market Value (USD Million) (2025-2032) By Types

Table 55: Europe Market Value (USD Million) (2025-2032) By Country

Table 56: Europe Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Types

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 59: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 61: South America Market Value (USD Million) (2025-2032) By Country

Table 62: South America Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Types

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 65: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 67: Research Programs/Design For This Report

Table 68: Key Data Information From Secondary Sources

Table 69: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Intravascular Ultrasound Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	800.00 million
Revenue forecast in 2033	1.65 billion
Growth rate	CAGR of 9.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific Corporation; Philips Healthcare; Volcano Corporation; Siemens Healthcare; GE Healthcare; Avinger Inc.; Terumo Corporation; InfraReDx
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Regulatory scrutiny in key regions, including stringent FDA and CE marking requirements, delays product launches. Compliance costs also pressure smaller manufacturers, reducing market agility.

Opportunities2 items

Challenges2 items

Price competition from low-cost alternatives in Asia-Pacific threatens profit margins. Established players must balance innovation with cost optimization to maintain market share.

Market Segmentation

Loading chart…

Intravascular Ultrasound Devices Segmentation Breakdown8 items

Application

Coronary Diagnostic

Coronary Intervention

Coronary Research

Other

Types

IVUS Consoles

IVUS Accessories

Regional Insights

Loading chart…

Key Regional Drivers5 items

North America: Advanced healthcare infrastructure, high R&D spending, and strong reimbursement policies.

Europe: Aging population, EU medical device regulations, and public-private collaboration.

Asia Pacific: Rising cardiovascular disease incidence, government-funded hospital upgrades, and growing private healthcare access.

Latin America: Expanding insurance coverage and rising adoption of minimally invasive procedures.

Middle East & Africa: Urbanization, diaspora healthcare demand, and strategic partnerships with global device manufacturers.

Competitive Landscape

Boston Scientific Corporation: Innovation pipeline for catheter-based imaging solutions

Philips Healthcare: OEM tie-ups for integrated cardiovascular diagnostic systems

Volcano Corporation: Premium pricing with AI-enhanced image processing tools

Siemens Healthcare: Regional expansion in Asia-Pacific through joint ventures

GE Healthcare: Vertical integration to reduce component sourcing costs

Avinger Inc.: Local manufacturing in emerging markets for cost efficiency

Key Intravascular Ultrasound Devices Companies8 items

Boston Scientific Corporation

Philips Healthcare

Volcano Corporation

Siemens Healthcare

GE Healthcare

Avinger Inc.

Terumo Corporation

InfraReDx

Market Ecosystem

Raw material/component suppliers — provide specialized polymers, transducers, and electronic components for device construction

OEMs/Manufacturers — design, assemble, and validate commercial IVUS systems for regulatory approval

Technology providers — develop proprietary imaging software and signal processing algorithms for device integration

Distributors/Channel partners — facilitate market access through direct sales teams or third-party networks to healthcare facilities

Service providers/After-sales support — offer device calibration, maintenance, and training for clinical staff

End users — include interventional cardiologists and vascular surgeons deploying IVUS for diagnostic and procedural guidance

Regulators/Standards bodies — oversee device conformity to safety, performance, and clinical efficacy requirements

Recent Industry Insights

Analyst Overview

Table of Contents